CIK 0001022079
- Large accelerated filer
QUEST DIAGNOSTICS INC
Sign in to watch- Ticker
- DGX
- Exchange
- NYSE
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 161387862
- Phone
- +1 973-520-2700
- Business address
- 500 PLAZA DRIVE, SECAUCUS, NJ, 07094
- Former names
- CORNING CLINICAL LABORATORIES INC
- 4 Grant or award Director acquired 1,482 shares (grant or award)
- 4 Grant or award Director acquired 1,482 shares (grant or award)
- 4 Grant or award Director acquired 1,482 shares (grant or award)
- 4 Grant or award Director acquired 1,482 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Planned sale SVP, Clinical Solutions sold 1,760 shares at $140.00 ($246,400)
- 4 Grant or award Director acquired 81 shares (grant or award)
- 4 Grant or award SVP, Clinical Solutions acquired 45 shares (grant or award)
- 4 Grant or award SVP for Diagnostic Services acquired 69 shares (grant or award)
- 4 Grant or award Executive Vice President & CFO acquired 24 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes SVP & Chief Commercial Officer gave up 170 shares (to pay taxes)
- 4 Shares withheld for taxes SVP for Diagnostic Services gave up 114 shares (to pay taxes)
- 4 Shares withheld for taxes SVP for Diagnostic Services gave up 333 shares (to pay taxes)
- 4 Planned sale EVP, Regional Businesses sold 6,744 shares at an average $126.45 ($852,769)
- 4 Planned sale SVP & General Counsel sold 5,611 shares at $125.88 ($706,313)
- 4 Shares withheld for taxes SVP, Clinical Solutions gave up 273 shares (to pay taxes)
- 4 Shares withheld for taxes Executive Vice President & CFO gave up 656 shares (to pay taxes)
- 4 Shares withheld for taxes CEO and President gave up 5,020 shares (to pay taxes)
- 4 Shares withheld for taxes SVP of Molecular Gen & Oncol gave up 262 shares (to pay taxes)
Page 11 of 74 · 1,466 filings